Idarubincin

DRUG2 trials

Sponsors

MedImmune LLC, Affiliated Hospital of Nantong University

Conditions

Acute Myeloid LeukemiaLeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute

Phase 1

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

CompletedNCT00086099

MedImmune LLCAcute Myeloid Leukemia, Leukemia

Start: 2004-07-31End: 2006-02-28Updated: 2009-01-29

Unknown Phase

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

RecruitingNCT06643962

Affiliated Hospital of Nantong UniversityLeukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Start: 2024-10-31End: 2027-10-31Target: 83Updated: 2024-11-12